4//SEC Filing
Ragosa Mark 4
Accession 0001835458-25-000003
CIK 0001730430other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:47 PM ET
Size
17.2 KB
Accession
0001835458-25-000003
Insider Transaction Report
Form 4
Ragosa Mark
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Class A Ordinary Share
2025-10-28$41.00/sh−100$4,100→ 31,086 total - Exercise/Conversion
Share Option
2025-10-28−100→ 19,900 totalExercise: $30.93Exp: 2028-09-19→ Class A Ordinary Share (100 underlying) - Exercise/Conversion
Class A Ordinary Share
2025-10-28$30.93/sh+100$3,093→ 31,186 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001835458
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:47 PM ET
- Size
- 17.2 KB